French pharmaceutical giant Sanofi said that it was in talks to sell a majority stake of its subsidiary that produces over-the-counter drugs to an American private equity firm for €15 billion. The proposed takeover is already proving highly controversial in France.

France freaks out over proposed sale of paracetamol-maker to American fund

French government threatens to use investment screening powers over the sale of Sanofi subsidiary.